Clinical Data in 21 Pregnant and/or Post-partum CHB Patients with 22 Infants who Received HBV Immunoprophylaxis.

Notes:aLiPA, INNO-LiPA HBV genotyping assay (Innogenetics N.V., Ghent, Belgium);bHBV DNA tested by commercial PCR (Abbott RealTime HBV assay M2000, sensitivity c Normal alanine aminotransferase (ALT) is dTE, transient elastography (FibroScan®, Echosens, France) for liver stiffness measurement;eSVD, spontaneous vaginal delivery; C/S, Caesarean section; HBIG, hepatitis B immune globin.fIn pending cases the infant has not reached the appropriate age to receive the 3-dose vaccine series or undergo testing for HBsAg and anti-HBs titres.Clinical Data in 21 Pregnant and/or Post-partum CHB Patients with 22 Infants who Received HBV Immunoprophylaxis.